gs-6201
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Adenosine A2b receptorANTAGONIST
ADORA2B antagonist
Chemistry & pharmacology
Loading structure…
SMILES
CCCn1c(=O)c2[nH]c(-c3cnn(Cc4cccc(C(F)(F)F)c4)c3)nc2n(CC)c1=O- Mol. weight
- 446.43 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL260933 ↗
Also known as
- 3-ethyl-1-propyl-8-(1-(3-trifluoromethylbenzyl)-1h-pyrazol-4-yl)-3,7-dihydropurine-2,6-dione
- cvt-6883
- cvt-6883
- cvt-6883
- gs 6201
- gs 6201
- gs-6201
- gs-6201
- gs-6201